Perry Andrew 4
4 · G1 Therapeutics, Inc. · Filed Jul 3, 2024
Insider Transaction Report
Form 4
Perry Andrew
Chief Commercial Officer
Transactions
- Award
Common Stock
2024-07-01+35,000→ 113,951 total
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award that vests 50% on July 1, 2025 and 50% on July 1, 2026, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]Represents (i) 12,806 shares of common stock; (ii) 3,000 RSUs from award granted on January 3, 2022; (iii) 12,075 RSUs from award granted on January 3, 2023; (iv) 17,500 RSUs from award granted on May 10, 2023; (v) 33,570 RSUs from award granted on January 3, 2024; and (vi) 35,000 RSUs from award granted on July 1, 2024.